GUTHRIE NAJLA has a total of 12 patent applications. Its first patent ever was published in 1999. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and United States. Its main competitors in its focus markets pharmaceuticals and foods and drinks are LEQUIO PHARMA CO LTD, HEBEI JUNLIN PHARMACEUTICAL CO LTD and K PAX PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 10 | |
#2 | Canada | 1 | |
#3 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Foods | |
#4 | Dairy products | |
#5 | Special foods |
# | Name | Total Patents |
---|---|---|
#1 | Guthrie Najla | 12 |
#2 | Kurowska Elzbieta Maria | 3 |
#3 | Kurowska Elzbieta | 2 |
#4 | Starr Martin | 1 |
#5 | Morley Karen | 1 |
#6 | Guthrie Robert A | 1 |
#7 | Koropatnick James | 1 |
#8 | Horowitz Robert M | 1 |
#9 | Leahy Margaret M | 1 |
#10 | Wenderoth Sondra | 1 |
Publication | Filing date | Title |
---|---|---|
WO2008035208A2 | The use of polymethoxyflavones for the non apoptotic inhibition of cancer cell growth | |
WO2007093853A2 | Compositions and methods for treatment and prevention of metabolic syndrome and its associated conditions with combinations of flavonoids, liminoids and tocotrienols | |
CA2346333A1 | Compositions and methods of inhibiting neoplastic diseases with compounds related to limocitrin and 5-desmethyl sinensetin |